Search filters

List of works by Velia Chiara Di Maio

A boceprevir failure in a patient infected with HCV genotype 1g: importance and limitations of virus genotyping prior to HCV protease-inhibitor-based therapy

scientific article published on 15 February 2013

Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen

scientific article published on 22 June 2013

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

scientific article published on 14 September 2016

Corrigendum to "Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018" [Drug Resist. Updates 37 (March) (2018) 17-39].

scientific article published on 18 April 2018

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

scientific article published on 24 November 2014

Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018.

scientific article published on 21 February 2018

Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents

scientific article published on 14 May 2015

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

scientific article

Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens

scientific article

Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice

scientific article published on 27 December 2014

May some HCV genotype 1 patients still benefit from dual therapy? The role of very early HCV kinetics

scientific article published on 20 October 2015

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

scientific article

Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study

scientific article published on 18 September 2017

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy.

scientific article

The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate+emtricitabine-containing HAART both in vivo and in vitro

scientific article published on 25 July 2016